Literature DB >> 22862865

The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease.

Ajay Nehra1, Graham Jackson, Martin Miner, Kevin L Billups, Arthur L Burnett, Jacques Buvat, Culley C Carson, Glenn R Cunningham, Peter Ganz, Irwin Goldstein, Andre T Guay, Geoff Hackett, Robert A Kloner, John Kostis, Piero Montorsi, Melinda Ramsey, Raymond Rosen, Richard Sadovsky, Allen D Seftel, Ridwan Shabsigh, Charalambos Vlachopoulos, Frederick C W Wu.   

Abstract

The Princeton Consensus (Expert Panel) Conference is a multispecialty collaborative tradition dedicated to optimizing sexual function and preserving cardiovascular health. The third Princeton Consensus met November 8 to 10, 2010, and had 2 primary objectives. The first objective focused on the evaluation and management of cardiovascular risk in men with erectile dysfunction (ED) and no known cardiovascular disease (CVD), with particular emphasis on identification of men with ED who may require additional cardiologic work-up. The second objective focused on reevaluation and modification of previous recommendations for evaluation of cardiac risk associated with sexual activity in men with known CVD. The Panel's recommendations build on those developed during the first and second Princeton Consensus Conferences, first emphasizing the use of exercise ability and stress testing to ensure that each man's cardiovascular health is consistent with the physical demands of sexual activity before prescribing treatment for ED, and second highlighting the link between ED and CVD, which may be asymptomatic and may benefit from cardiovascular risk reduction.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22862865      PMCID: PMC3498391          DOI: 10.1016/j.mayocp.2012.06.015

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  131 in total

1.  Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity).

Authors:  Paul D Thompson; David Buchner; Ileana L Pina; Gary J Balady; Mark A Williams; Bess H Marcus; Kathy Berra; Steven N Blair; Fernando Costa; Barry Franklin; Gerald F Fletcher; Neil F Gordon; Russell R Pate; Beatriz L Rodriguez; Antronette K Yancey; Nanette K Wenger
Journal:  Circulation       Date:  2003-06-24       Impact factor: 29.690

2.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Philip Greenland; Joseph S Alpert; George A Beller; Emelia J Benjamin; Matthew J Budoff; Zahi A Fayad; Elyse Foster; Mark A Hlatky; John McB Hodgson; Frederick G Kushner; Michael S Lauer; Leslee J Shaw; Sidney C Smith; Allen J Taylor; William S Weintraub; Nanette K Wenger; Alice K Jacobs
Journal:  Circulation       Date:  2010-11-15       Impact factor: 29.690

3.  The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis.

Authors:  Bhanu P Gupta; M Hassan Murad; Marisa M Clifton; Larry Prokop; Ajay Nehra; Stephen L Kopecky
Journal:  Arch Intern Med       Date:  2011-09-12

Review 4.  Uric acid in heart disease: a new C-reactive protein?

Authors:  Eswar Krishnan; Jeremy Sokolove
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

5.  Hormonal testing and pharmacologic treatment of erectile dysfunction: a clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Vincenza Snow; Thomas D Denberg; Donald E Casey; Mary Ann Forciea; Douglas K Owens; Paul Shekelle
Journal:  Ann Intern Med       Date:  2009-11-03       Impact factor: 25.391

6.  Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients.

Authors:  Michael Doumas; Alexandros Tsakiris; Stella Douma; Alkiviadis Grigorakis; Angelos Papadopoulos; Athina Hounta; Sotirios Tsiodras; Dimitrios Dimitriou; Helen Giamarellou
Journal:  Asian J Androl       Date:  2006-03       Impact factor: 3.285

7.  Erectile dysfunction and silent coronary artery disease: abnormal computed tomography coronary angiogram in the presence of normal exercise ECGs.

Authors:  G Jackson; S Padley
Journal:  Int J Clin Pract       Date:  2008-06       Impact factor: 2.503

8.  Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction.

Authors:  Giovanni Corona; Matteo Monami; Valentina Boddi; Michela Cameron-Smith; Alessandra D Fisher; Giulia de Vita; Cecilia Melani; Daniela Balzi; Alessandra Sforza; Gianni Forti; Edoardo Mannucci; Mario Maggi
Journal:  J Sex Med       Date:  2010-01-25       Impact factor: 3.802

9.  Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

Authors:  T Hugh Jones; Stefan Arver; Hermann M Behre; Jacques Buvat; Eric Meuleman; Ignacio Moncada; Antonio Martin Morales; Maurizio Volterrani; Ann Yellowlees; Julian D Howell; Kevin S Channer
Journal:  Diabetes Care       Date:  2011-03-08       Impact factor: 19.112

Review 10.  Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database.

Authors:  F Giuliano; G Jackson; F Montorsi; A Martin-Morales; P Raillard
Journal:  Int J Clin Pract       Date:  2009-11-09       Impact factor: 2.503

View more
  80 in total

1.  Erectile dysfunction as a marker for cardiovascular disease diagnosis and intervention: a cost analysis.

Authors:  Alexander W Pastuszak; Daniel A Hyman; Naveen Yadav; Guilherme Godoy; Larry I Lipshultz; Andre B Araujo; Mohit Khera
Journal:  J Sex Med       Date:  2015-03-02       Impact factor: 3.802

2.  Current Diagnosis and Management of Erectile Dysfunction.

Authors:  Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2014-09

Review 3.  The evaluation and treatment of prostate-related LUTS in the primary care setting: the next STEP.

Authors:  Matt T Rosenberg; David Staskin; John Riley; Grannum Sant; Martin Miner
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

4.  Microvascular endothelial dysfunction predicts the development of erectile dysfunction in men with coronary atherosclerosis without critical stenoses.

Authors:  Martin Reriani; Andreas J Flammer; Jing Li; Megha Prasad; Charanjit Rihal; Abhiram Prasad; Ryan Lennon; Lilach O Lerman; Amir Lerman
Journal:  Coron Artery Dis       Date:  2014-11       Impact factor: 1.439

5.  A critical analysis of the 2014 CUA guidelines for erectile dysfunction: Is there more that can be done?

Authors:  Jason R Kovac
Journal:  Can Urol Assoc J       Date:  2015 Jan-Feb       Impact factor: 1.862

6.  Percutaneous transluminal coronary angioplasty for acute myocardial infarction: the impact on sexual function in men.

Authors:  C Goławski; M Dłużniewski; E Kostarska-Srokosz; K Nowosielski; J Syska-Sumińska; M Chmielewski; R Kowalczyk
Journal:  Int J Impot Res       Date:  2017-04-20       Impact factor: 2.896

Review 7.  Psychological Impacts of Male Sexual Dysfunction in Pelvic Cancer Survivorship.

Authors:  David K Twitchell; Daniela A Wittmann; James M Hotaling; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2019-03-26

8.  Let's talk about sex.

Authors:  Graham Jackson
Journal:  Clin Res Cardiol       Date:  2013-02-21       Impact factor: 5.460

Review 9.  Erectile dysfunction in the elderly male.

Authors:  Mehmet İlker Gökçe; Önder Yaman
Journal:  Turk J Urol       Date:  2017-08-03

10.  Cardiovascular rehabilitation, ballroom dancing and sexual dysfunction.

Authors:  Tales de Carvalho; Ana Inês Gonzáles; Sabrina Weiss Sties; Gabriela Maria Dutra de Carvalho
Journal:  Arq Bras Cardiol       Date:  2013-12       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.